IEQ Capital’s Wave Life Sciences WVE Stock Holding History

IEQ Capital’s Portfolio WVE Stock Details WVE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$618K	Buy	106,446 +83,914	+372%	+$556K	﹤0.01%	1310
2026 Q1	$163K	Buy	+22,532	New	+$294K	﹤0.01%	1739

Other funds holding WVE

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

GSK plc London $602M AUM

Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

6CM

683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

RAM

Readystate Asset Management Chicago, Illinois $2.93B AUM 18.57% 1-Year Est. Return

IEQ Capital's WVE Position: Q2 2026 in Review

IEQ Capital increased its Wave Life Sciences (WVE) stake by 372% in Q2 2026, buying an estimated $556K and bringing the position to 106,446 shares worth $618K. The position accounts for ﹤0.01% of the portfolio, ranked #1310.

IEQ Capital first reported a position in WVE in Q1 2026 and has held it in 2 quarters since. 239 funds tracked by Wall St. Rank hold WVE as of Q2 2026.

IEQ Capital held 106,446 shares of Wave Life Sciences worth $618K as of Q2 2026.
IEQ Capital bought 83,914 Wave Life Sciences shares in Q2 2026, an estimated $556K.
Wave Life Sciences made up ﹤0.01% of IEQ Capital's portfolio in Q2 2026, its #1310 holding.
IEQ Capital first reported a position in Wave Life Sciences in Q1 2026 and has held it in 2 quarters since.
239 funds tracked by Wall St. Rank held Wave Life Sciences as of Q2 2026.

Based on IEQ Capital's 13F filing for Q2 2026, filed 11 Aug 2026.